Pourquoi les chiffres des cas de dengue restent bas - Nouvelle-Calédonie la
la1ere.francetvinfo.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from la1ere.francetvinfo.fr Daily Mail and Mail on Sunday newspapers.
MacArthur Foundation awards $100 million to end homelessness in America
nationalgeographic.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nationalgeographic.com Daily Mail and Mail on Sunday newspapers.
Nick Jewell recognised for lifetime contribution to the application of statistical science to epidemiology
lshtm.ac.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lshtm.ac.uk Daily Mail and Mail on Sunday newspapers.
Published: Mar 08, 2021
Investments towards research of live attenuated vaccines for mosquito-borne disease treatments in major population centers is generating better prospects for sales.
Fact.MR Rockville, MD: An ongoing report on the mosquito-borne disease treatments market by market research firm Fact.MR has projected positive growth prospects for 2021. The covid-19 pandemic has moderately impacted the industry owing to the redirection of healthcare facilities towards the new threat of the coronavirus. However, continued concerns over vector-borne disease is expected to sustain steady growth in the market in the coming years.
According to the World Mosquito Program, close to 700 million people globally contract mosquito borne ailments annually, which results in approximately a million deaths. In recent years, dengue cases have risen strongly and 40 percent of the global population is considered to be at risk, with around 25,000 patients succumbing to the disease annually.